R Ben-Levy

2.6k total citations
18 papers, 2.3k citations indexed

About

R Ben-Levy is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, R Ben-Levy has authored 18 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in R Ben-Levy's work include HER2/EGFR in Cancer Research (5 papers), HIV Research and Treatment (4 papers) and RNA Interference and Gene Delivery (4 papers). R Ben-Levy is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), HIV Research and Treatment (4 papers) and RNA Interference and Gene Delivery (4 papers). R Ben-Levy collaborates with scholars based in Israel, United Kingdom and United States. R Ben-Levy's co-authors include Yosef Shaul, Hugh F. Paterson, Yosef Yarden, Ouriel Faktor, Elior Peles, Marie A. Bogoyevitch, Albert J. Ketterman, Stephen J. Fuller, Judith Brown and Alan Ashworth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

R Ben-Levy

18 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Ben-Levy Israel 18 1.5k 609 451 276 233 18 2.3k
Hsing‐Jien Kung United States 36 2.1k 1.4× 1.1k 1.8× 529 1.2× 256 0.9× 514 2.2× 91 3.9k
Christian Stratowa Austria 22 1.5k 1.0× 438 0.7× 244 0.5× 337 1.2× 1.1k 4.5× 28 3.3k
Raymond Davis United States 9 1.4k 0.9× 1.1k 1.7× 276 0.6× 280 1.0× 967 4.2× 12 3.5k
John R. Jenkins United Kingdom 30 2.0k 1.3× 1.5k 2.5× 587 1.3× 93 0.3× 328 1.4× 60 3.5k
Manfred Koegl Germany 26 2.7k 1.8× 794 1.3× 330 0.7× 124 0.4× 334 1.4× 37 3.3k
Peter Liston Canada 37 2.8k 1.8× 657 1.1× 682 1.5× 102 0.4× 658 2.8× 50 3.9k
Jean-Philippe Stéphan France 25 1.3k 0.8× 405 0.7× 299 0.7× 306 1.1× 343 1.5× 36 2.2k
Michael A. Davitz United States 16 986 0.6× 211 0.3× 443 1.0× 208 0.8× 563 2.4× 21 2.2k
K R Auger United States 16 1.5k 1.0× 511 0.8× 248 0.5× 136 0.5× 879 3.8× 22 2.7k
Hanna Berissi Israel 23 2.2k 1.4× 418 0.7× 826 1.8× 84 0.3× 536 2.3× 25 3.2k

Countries citing papers authored by R Ben-Levy

Since Specialization
Citations

This map shows the geographic impact of R Ben-Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Ben-Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Ben-Levy more than expected).

Fields of papers citing papers by R Ben-Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Ben-Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Ben-Levy. The network helps show where R Ben-Levy may publish in the future.

Co-authorship network of co-authors of R Ben-Levy

This figure shows the co-authorship network connecting the top 25 collaborators of R Ben-Levy. A scholar is included among the top collaborators of R Ben-Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Ben-Levy. R Ben-Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zauberman, Ayelet, Dov Zipori, Meir Krupsky, & R Ben-Levy. (1999). Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene. 18(26). 3886–3893. 80 indexed citations
2.
Ben-Levy, R, et al.. (1998). Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Current Biology. 8(19). 1049–1057. 286 indexed citations
3.
Cano, Eva, Yair N. Doza, R Ben-Levy, Phillip Cohen, & Louis C. Mahadevan. (1996). Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2.. PubMed. 12(4). 805–12. 78 indexed citations
4.
Bogoyevitch, Marie A., Judith Brown, Albert J. Ketterman, et al.. (1996). Stimulation of the Stress-Activated Mitogen-Activated Protein Kinase Subfamilies in Perfused Heart. Circulation Research. 79(2). 162–173. 470 indexed citations
5.
Gilboa, Lilach, R Ben-Levy, Yosef Yarden, & Yoav I. Henis. (1995). Roles for a Cytoplasmic Tyrosine and Tyrosine Kinase Activity in the Interactions of Neu Receptors with Coated Pits. Journal of Biological Chemistry. 270(13). 7061–7067. 65 indexed citations
6.
Ben-Levy, R, Ian Leighton, Yair N. Doza, et al.. (1995). Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.. The EMBO Journal. 14(23). 5920–5930. 172 indexed citations
7.
Ben-Levy, R, Hugh F. Paterson, Chris Marshall, & Yosef Yarden. (1994). A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway.. The EMBO Journal. 13(14). 3302–3311. 173 indexed citations
8.
Orr‐Urtreger, Avi, R Ben-Levy, D Wen, et al.. (1993). Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.. Proceedings of the National Academy of Sciences. 90(5). 1867–1871. 100 indexed citations
9.
10.
Ben-Levy, R, et al.. (1992). An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.. Journal of Biological Chemistry. 267(24). 17304–17313. 38 indexed citations
11.
Peles, Elior, Raphael Lamprecht, R Ben-Levy, Eldad Tzahar, & Yosef Yarden. (1992). Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.. Journal of Biological Chemistry. 267(17). 12266–12274. 79 indexed citations
12.
Dikstein, Rivka, Ouriel Faktor, R Ben-Levy, & Yosef Shaul. (1990). Functional Organization of the Hepatitis Β Virus Enhancer. Molecular and Cellular Biology. 10(7). 3683–3689. 63 indexed citations
13.
Faktor, Ouriel, et al.. (1990). A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. Journal of Virology. 64(4). 1861–1863. 50 indexed citations
14.
Ben-Levy, R, et al.. (1989). Cellular Factors That Interact with the Hepatitis B Virus Enhancer. Molecular and Cellular Biology. 9(4). 1804–1809. 43 indexed citations
15.
Ben-Levy, R, et al.. (1989). Cellular factors that interact with the hepatitis B virus enhancer.. Molecular and Cellular Biology. 9(4). 1804–1809. 90 indexed citations
16.
Shaul, Yosef & R Ben-Levy. (1987). Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences.. The EMBO Journal. 6(7). 1913–1920. 112 indexed citations
17.
Shaul, Yosef, R Ben-Levy, & Tali De-Medina. (1986). High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter.. The EMBO Journal. 5(8). 1967–1971. 87 indexed citations
18.
Rozenblatt, Shmuel, Orly Eizenberg, R Ben-Levy, Vered Lavie, & William J. Bellini. (1985). Sequence homology within the morbilliviruses. Journal of Virology. 53(2). 684–690. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026